Combined Synopsis/SolicitationPosted Sep 10, 2026·Responses due Sep 17, 2026

Facilitating Research, Programmatic, and Operational Support of the National Amyotrophic Lateral Sclerosis� (ALS) Biorepository in support of the ALS Registry Act

CDC · CDC OFFICE OF ACQUISITION SERVICES

Stage
Open solicitation
NAICS
621991
Value
Not stated
Solicitation
75D301-Q-26-95343
Set-aside
Small Business Set Aside - Total
PSC
R499
Place
GA, USA
Contact
Howard D. Bish (uwo8@cdc.gov)
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 75D301-Q-26-95343 in this department, oldest first.

Early notice
None posted
Solicitation
  • Sep 10, 2026 · this notice
    Combined Synopsis/Solicitation
  • Sep 10, 2026
    Combined Synopsis/Solicitation
    Open
  • Sep 14, 2026
    Combined Synopsis/Solicitation
    Open
Award
Not yet. Too few past cases at this agency to estimate timing (7 found; 10 needed).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Decide bid or no bid before the response deadline.
  • Look at the past winners for likely competitors and teaming partners.
  • Follow the opportunity to hear about amendments and the award.

What the notice says

This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with FAR Part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued. Solicitation number 75D301-26-Q-95343 is issued as a Request for Quotation for the project titled: "Facilitating Research, Programmatic, and Operational Support of the National Amyotrophic Lateral Sclerosis� (ALS) Biorepository in support of the ALS Registry Act." This acquisition is set-aside for small business concerns. This solici… (show all)

tation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. (ii) A list of line-item number(s) and items, quantities, and units of measure can be found in the solicitation document. (iii) Description of requirements for the items to be acquired, including documentation supporting any brand name descriptions (see 12.102). See Solicitation document. (iv) Date(s) and place(s) of delivery and acceptance and f.o.b. point (see part 47). Period of performance is anticipated to be 9/28/2026 - 9/27/2031, inclusive of the base period and all option periods. (v) A list of solicitation provisions that apply to the acquisition (see 12.205(a)). See solicitation document. (vi) A list of contract clauses that apply to the acquisition (see 12.205(b)). See solicitation document. (vii) The date, time, and place for receipt of offer and point of contact. Offers are due 9/17/2026 10 AM ET to uwo8@cdc.gov. (viii) Any other additional information required by 5.101(c). Questions are due 9/11/2026 5 PM ET to uwo8@cdc.gov.

Who won similar work

111 award notices on SAM.gov in the last 24 months. Match: Same agency (CDC), any industry: a loose match.

Loose match: same agency, any industry. Read the titles before treating these as competitors.

WinnerAwardsValueLast
POLOLEI SOLUTIONS, LLC5$3.3MJul 21, 2026
GLAXOSMITHKLINE, LLC3$1.7BMar 27, 2026
RESEARCH TRIANGLE INSTITUTE Durham NC 27709 USA3$9.8MJun 4, 2026
MERCK SHARP & DOHME LLC · $MRK2$4.5BSep 14, 2026
Pfizer New York NY 10001 USA2$1.2BJun 3, 2026
SEQIRUS USA INC2$663.9MDec 31, 2024
Moderna Princeton NJ 08540 USA2$314.2MJun 3, 2026
SANOFI PASTEUR INC.2$233.3MDec 31, 2024
AMERICAN TYPE CULTURE COLLECTION Manassas VA 20110 USA2$155.3MMay 18, 2026
ASTRAZENECA PHARMACEUTICALS LP2$61.0MDec 31, 2024

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.

Latest awards

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 1 of these past winners lobbied Centers For Disease Control & Prevention (CDC) since 2024 (4 filings)
  • 0 of their lobbyists list a past Centers For Disease Control & Prevention (CDC) job
  • $99K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Energy and Commerce, Senate Committee on Appropriations, Senate Committee on Health, Education, Labor, and Pensions
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 0 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.

  • 1 of the past winners are listed companies
  • 0 insider buys and 7 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.